A valid prescription requires a telehealth consultation with a licensed provider. No medication is dispensed without clinical evaluation.
IGF-1 LR3 200mcg/mL
Investigational Long-Acting IGF-1 Analog
Compound Specifications
IGF-1 LR3 200mcg/mL
Investigational Long-Acting IGF-1 Analog
IGF-1 LR3 is an engineered analog of insulin-like growth factor 1 with an 83-amino acid chain that has been investigated in preclinical research for its potential interactions with IGF-1 receptors and cellular growth pathways. This is an investigational compound; these statements have not been evaluated by the FDA and it is not intended to diagnose, treat, cure, or prevent disease.
In laboratory research models, IGF-1 LR3 has been studied for potential binding to IGF-1 receptors and interactions with satellite cell signaling and nutrient partitioning pathways. Results may vary; individual outcomes depend on baseline health, adherence, and other factors.
Documented Therapeutic Benefits
Results may vary. Individual outcomes depend on adherence, baseline health, and other factors.
Administer pre- or post-workout per clinical titration.
Frequently Asked Clinical Questions
What does LR3 stand for?
Long Arg3 — an arginine substitution at position 3 studied in research for its potential to reduce binding to inhibitory proteins. This is investigational research only; results may vary.